B. Jiang

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Treatment of Myelodysplastic Syndrome with Cyclosporin A

B. Jiang, M. Gong, M. Guan, 2007, International journal of hematology.

S100A16 suppresses the growth and survival of leukaemia cells and correlates with relapse and relapse free survival in adults with Philadelphia chromosome‐negative B‐cell acute lymphoblastic leukaemia

Jiamin Zhang, Li-xin Wu, Jing Zhang, 2019, British journal of haematology.

Molecular responses of late chronic phase chronic myeloid leukemia patients after achieving complete cytogenetic responses with imatinib treatment: a 6-year follow-up

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2008, Annals of Hematology.

Allogeneic hematopoietic SCT in combination with tyrosine kinase inhibitor treatment compared with TKI treatment alone in CML blast crisis

Hao Jiang, Q. Jiang, B. Jiang, 2014, Bone Marrow Transplantation.

Tamibarotene Compared to All-Trans Retinoic Acid (ATRA) As Add-on to Arsenic Trioxide (ATO) in Subjects with Relapsed Acute Promyelocytic Leukemia (APL)

Jun Yu Li, B. Jiang, Jianxiang Wang, 2015 .

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

Hao Jiang, R. Gale, Hao Jiang, 2016, BMC Cancer.

Case Report: Dacomitinib is effective in lung adenocarcinoma with rare EGFR mutation L747P and brain metastases

B. Jiang, Jingxun Wu, Weixi Guo, 2022, Frontiers in Oncology.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

Ya-Zhen Qin, Hao Jiang, Q. Jiang, 2015, Leukemia & lymphoma.

Imatinib Mesylate Resistance in a Chronic Myeloid Leukemia Patient with a Novel e8a2 BCR-ABL Transcript Variant

Yan Liu, Hao Jiang, Q. Jiang, 2008, Acta Haematologica.

let-7-repressesed Shc translation delays replicative senescence

M. Gorospe, Wengong Wang, Y. Dou, 2013, Aging cell.

Bortezomib improves progression‐free survival in multiple myeloma patients overexpressing preferentially expressed antigen of melanoma

B. Jiang, Yan-rong Liu, Y. Lai, 2014, Chinese medical journal.

MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial.

Yu Wang, Huan Chen, Jin Lu, 2013, Blood.

The superiority of haploidentical related stem cell transplantation over chemotherapy alone as postremission treatment for patients with intermediate- or high-risk acute myeloid leukemia in first complete remission.

Hao Jiang, Q. Jiang, B. Jiang, 2012, Blood.

Hao Jiang, Q. Jiang, B. Jiang, 2014, Bone Marrow Transplantation.

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

Q. Jiang, B. Jiang, Yan-rong Liu, 2013, Leukemia & lymphoma.

Tetra-arsenic tetra-sulfide for the treatment of acute promyelocytic leukemia: a pilot report.

B. Jiang, Yan-rong Liu, Qin Wang, 2002, Blood.

CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.

Hao Jiang, Q. Jiang, B. Jiang, 2013, Leukemia research.

Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study

Yan Liu, Hua Jiang, B. Jiang, 2017, Cancer Chemotherapy and Pharmacology.

MMY-3002: A Phase 3 Study Comparing Bortezomib-Melphalan-Prednisone (VMP) with Melphalan-Prednisone (MP) in Newly Diagnosed Multiple Myeloma.

M. Dimopoulos, A. Palumbo, P. Richardson, 2007 .

The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2014, Molecular Cancer.

Persistent overall survival benefit and no increased risk of second malignancies with bortezomib-melphalan-prednisone versus melphalan-prednisone in patients with previously untreated multiple myeloma.

D. Esseltine, M. Dimopoulos, A. Palumbo, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics

R. Gale, Hao Jiang, Q. Jiang, 2017, Oncotarget.

[The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].

B. Jiang, Yan-rong Liu, G. Ruan, 2013, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[Comparison of efficacy and prognostic factors in elderly acute myelogenous patients with MA or CAG induction chemotherapy regimen].

Q. Jiang, B. Jiang, Ting Zhao, 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[Prognostic significance of early assessment of minimal residual disease in acute myeloid leukemia with mutated NPM1 patients].

Q. Jiang, B. Jiang, G. Ruan, 2017, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

NPM1-mutated acute myeloid leukemia of monocytic or myeloid origin exhibit distinct immunophenotypes.

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2013, Leukemia research.

Mutation topography and risk stratification for de novo acute myeloid leukaemia with normal cytogenetics and no nucleophosmin 1 (NPM1) mutation or Fms‐like tyrosine kinase 3 internal tandem duplication (FLT3‐ITD)

Ying Sun, Li-xin Wu, Hao Jiang, 2020, British journal of haematology.

[Clinical characteristics of acute myeloid leukemia with t (16;21) (p11;q22):nine cases report and literature review].

B. Jiang, Y. Lai, Y. Wang, 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Detecting PML-RARα transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR

B. Jiang, Yan-rong Liu, Honghu Zhu, 2007 .

Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.

B. Jiang, Yan-rong Liu, Honghu Zhu, 2007, Chinese medical journal.

Clinicopathological features and prognostic analysis of 77 patients with multiple primary cancers.

B. Jiang, R. Zheng, Meiqun Cao, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2005, Zhongguo shi yan xue ye xue za zhi.

Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all-trans retinoic acid and arsenic compound-based combined therapies

Hao Jiang, B. Jiang, Xiaojun Huang, 2013, Oncology letters.

去甲氧柔红霉素10和8 mg/m2联合阿糖胞苷治疗初发急性髓系白血病的比较性研究

Hao Jiang, Q. Jiang, B. Jiang, 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Updated Follow-up and Results of Subsequent Therapy in the Phase III VISTA Trial: Bortezomib Plus Melphalan–Prednisone Versus Melphalan–Prednisone in Newly Diagnosed Multiple Myeloma

D. Esseltine, M. Dimopoulos, A. Palumbo, 2008 .

Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia

B. Jiang, Yan-rong Liu, Xiao-jun Huang, 2009, Annals of Hematology.

Prevalence and Prognostic Significance of c-KIT Mutations in Core Binding Factor Acute Myeloid Leukemia: A Comprehensive Large-Scale Study from a Single Chinese Center

Hao Jiang, Q. Jiang, B. Jiang, 2014 .

Continued Overall Survival Benefit After 5 Years' Follow-up with Bortezomib-Melphalan-Prednisone (VMP) Versus Melphalan-Prednisone (MP) in Patients with Previously Untreated Multiple Myeloma, and No Increased Risk of Second Primary Malignancies: Final Results of the Phase 3 VISTA Trial

D. Esseltine, M. Dimopoulos, A. Palumbo, 2011 .

A Phase I/IIa Study of Lemzoparlimab, a Monoclonal Antibody Targeting CD47, in Patients with Relapsed and/or Refractory Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS): Initial Phase I Results

B. Jiang, Jianxiang Wang, Yanni Zhang, 2020 .

Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia

R. Gale, Hao Jiang, Q. Jiang, 2016, BMC Cancer.

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.

Bortezomib Plus Melphalan–Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan–Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use.

D. Esseltine, M. Dimopoulos, A. Palumbo, 2009 .

Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: Results from a prospective, multi-center study.

Q. Jiang, B. Jiang, Yan-rong Liu, 2014, American journal of hematology.

Expression of the multidrug resistance gene in leukemic cells

B. Jiang, T. Bai, Xiaorong Liu, 1993 .

[The efficacy of imatinib mesylate for 124 patients with chronic myeloid leukemia in accelerated and blastic phase].

Hao Jiang, Q. Jiang, B. Jiang, 2007, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[Efficacy and safety evaluation of imatinib in the treatment of patients with chronic granulocytic leukemia in accelerated phase].

Hao Jiang, Q. Jiang, B. Jiang, 2004, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy

Hao Jiang, Q. Jiang, B. Jiang, 2015, Leukemia & lymphoma.

Bortezomib Plus Thalidomide Treatment of Newly Diagnosed Patients with Multiple Myeloma - Efficacy and Neurotoxicity: Results of a Multicenter Study.

B. Jiang, L. Qiu, Li Yu, 2007 .

Q. Jiang, B. Jiang, Yan-rong Liu, 2012, American journal of hematology/oncology.

成人Ph染色体阴性急性淋巴细胞白血病患者预后因素分析

Hao Jiang, Q. Jiang, B. Jiang, 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

PRAME and WT1 transcripts constitute a good molecular marker combination for monitoring minimal residual disease in myelodysplastic syndromes

Q. Jiang, B. Jiang, Yan-rong Liu, 2013, Leukemia & lymphoma.

Frequency and allele burden of CALR mutations in Chinese with essential thrombocythemia and primary myelofibrosis without JAK2(V617F) or MPL mutations.

R. Gale, Hao Jiang, Q. Jiang, 2015, Leukemia research.